240 related articles for article (PubMed ID: 3865715)
1. The isolation of natural killer (NK)-resistant variants of the K562 cell line by mutagenesis and selection with antibodies which inhibit NK cell-mediated lysis.
Werkmeister JA; Triglia T; Burns GF
Cell Immunol; 1985 Apr; 92(1):123-33. PubMed ID: 3865715
[TBL] [Abstract][Full Text] [Related]
2. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
Werkmeister JA; Burns GF; Triglia T
J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of human natural killer recognition demonstrated by cloned effector cells and differential blocking of cytotoxicity with monoclonal antibodies.
Pawelec G; Newman W; Schwulera U; Wernet P
Cell Immunol; 1985 Apr; 92(1):31-40. PubMed ID: 3865716
[TBL] [Abstract][Full Text] [Related]
4. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
Shanahan F; Brogan MD; Newman W; Targan SR
J Immunol; 1986 Jul; 137(2):723-6. PubMed ID: 3487579
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
6. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
Bolhuis RL; Roozemond RC; van de Griend RJ
J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
[TBL] [Abstract][Full Text] [Related]
7. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
8. Differences of K562 leukemia cell clones in the pattern of monoclonal antibody binding and NK cell susceptibility.
Hering S; Böttger V; Jantscheff P; Micheel B
Biomed Biochim Acta; 1986; 45(5):673-9. PubMed ID: 3463302
[TBL] [Abstract][Full Text] [Related]
9. A novel antigenic cell surface protein associated with T200 is involved in the post-activation stage of human NK cell-mediated lysis.
Burns GF; Werkmeister JA; Triglia T
J Immunol; 1984 Sep; 133(3):1391-6. PubMed ID: 6379048
[TBL] [Abstract][Full Text] [Related]
10. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
Perl A; Looney RJ; Ryan DH; Abraham GN
J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
[TBL] [Abstract][Full Text] [Related]
11. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes.
Frey JL; Bino T; Kantor RR; Segal DM; Giardina SL; Roder J; Anderson S; Ortaldo JR
J Exp Med; 1991 Dec; 174(6):1527-36. PubMed ID: 1720812
[TBL] [Abstract][Full Text] [Related]
13. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2).
Ciccone E; Pende D; Viale O; Than A; Di Donato C; Orengo AM; Biassoni R; Verdiani S; Amoroso A; Moretta A
J Exp Med; 1992 Oct; 176(4):963-71. PubMed ID: 1328466
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Schmidt RE; Bartley G; Levine H; Schlossman SF; Ritz J
J Immunol; 1985 Aug; 135(2):1020-5. PubMed ID: 3924996
[TBL] [Abstract][Full Text] [Related]
15. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
[TBL] [Abstract][Full Text] [Related]
16. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
[TBL] [Abstract][Full Text] [Related]
18. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
19. K562 cells induced to differentiate by phorbol ester tumor promotors resist NK lysis.
Dokhelar MC; Garson D; Wakasugi H; Tabilio A; Testa U; Vainchenker W; Tursz T
Cell Immunol; 1984 Sep; 87(2):389-99. PubMed ID: 6205768
[TBL] [Abstract][Full Text] [Related]
20. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
